In premature neonates, this leads to infant respiratory distress syndrome.

Infant respiratory distress syndrome, previously known as hyaline membrane disease.

Lung surfactant is being developed as a potential treatment for infant respiratory distress syndrome, a leading cause of death in premature babies.

Steroids may be administered to stimulate the babies' lung development and decrease the risk of infant respiratory distress syndrome.

Reduced production of surfactant indicates decreased lung maturity and is a high risk factor for infant respiratory distress syndrome.

However, surfactant decreases the alveolar surface tension, as seen in cases of premature infants suffering from infant respiratory distress syndrome.

Amniocentesis can predict fetal lung maturity, which is inversely correlated to the risk of infant respiratory distress syndrome.

Infant respiratory distress syndrome (RDS)

Infant respiratory distress syndrome, in turn, is the leading cause of death in preterm infants, affecting about 1% of newborn infants.

Lucinactant (trade name Surfaxin) is a liquid medication used to treat Infant Respiratory Distress Syndrome in infants.

At the end of that decade it was discovered that the lack of surfactant caused infant respiratory distress syndrome (IRDS).

Other drugs approved by the United States and many other countries include drugs for schizophrenia, fibromyalgia, obesity, influenza, and infant respiratory distress syndrome.

With insufficient pulmonary surfactant, the pulmonary alveoli collapse, causing atelectasis (in infants, infant respiratory distress syndrome)

Infant respiratory distress syndrome (IRDS) is a syndrome caused by lack of surfactant in the lungs of premature infants.

Complications of extreme prematurity may include intracranial hemorrhage, chronic bronchopulmonary dysplasia (see Infant respiratory distress syndrome), or retinopathy of prematurity.

Infant respiratory distress syndrome (IRDS) is caused by lack of surfactant, commonly suffered by premature babies born before 28-32 weeks of gestation.

ARDS formerly most commonly signified adult respiratory distress syndrome to differentiate it from infant respiratory distress syndrome in premature infants.

Died: Patrick Bouvier Kennedy, two-day-old son of President John F. Kennedy, of infant respiratory distress syndrome.

Most cases of infant respiratory distress syndrome can be ameliorated or prevented if mothers who are about to deliver prematurely can be given glucocorticoids, one group of hormones.

Infant respiratory distress syndrome (RDS), which is a complication of premature birth, also known as hyaline membrane disease (HMD)

Deficiency in SP-A levels is associated with infant respiratory distress syndrome in prematurely born infants with developmental insufficiency of surfactant production and structural immaturity in the lungs.

Hyaline Membrane Disease Infantile Respiratory Distress Syndrome IRDS surfactant protein-B deficiency Infant respiratory distress syndrome is a lung disorder that tends to affect premature infants.

Infant respiratory distress syndrome is the leading cause of death in preterm infants, and the main treatments are CPAP, in addition to administering surfactant and stabilizing the blood sugar, blood salts, and blood pressure.

Besides prematurity and extreme low birth-weight, common diseases cared for in a NICU include perinatal asphyxia, major birth defects, sepsis, neonatal jaundice, and Infant respiratory distress syndrome due to immaturity of the lungs.

However, adequate amounts of surfactant are not secreted until about 35 weeks of gestation - this is the main reason for increased incidence rates of Infant respiratory distress syndrome, which drastically reduces at ages above 35 weeks gestation.